Ophthalmology Grand Rounds: Robertson Lecture with Dr. J. Timothy Stout
| When |
Friday, March 6, 2026
7:00 to 8:00 a.m. PST
|
|---|---|
| Where |
|
| Contact Information |
Susan Minnieweather
Ophthalmology Continuing Medical Education
|
Joseph E. Robertson Jr. Lecture
Speaker
J. Timothy Stout, MD, PhD, MBA
Chair, Sid W. Richardson Professor, and Margarett Root Brown Chair
Director-Cullen Eye Institute and Chair-Department of Ophthalmology
Baylor College of Medicine
Course details
Talk Title: "Academic Ophthalmology 2036 – What should we think about NOW"
Learning Objectives
Participants will be able to:
- Better understand how AI may help and compromise healthcare in the USA.
- Discuss the crisis of ER ophthalmic coverage
Continuing medical education
Accreditation
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credits
OHSU School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure to Learners
Presenters/Moderators
J. Timothy Stout, MD, PhD, MBA - Is on the Data and Safety Monitoring Board for Ascidian Therapeutics, Inc., Beacon Therapeutics, Inc., Atsena Therapeutics, Inc., Cognition Therapeutics, Exegenesis Bio, Sanofi U.S. Services Inc., SparingVision, and SPARK Therapeutics, Inc., for which consulting Fees were received; is a Surgical Committee Member for Astellas for which consulting fees were received; is on the scientific advisory board of Nacuity Pharmaceuticals, Inc., for which stock options were received; is a consultant for BlueRock Therapeutics LP, Daiichi-Sankyo, Meira GTx, Oxford Science Enterprises, REGENXBIO, and SpliceBio, for which consulting fees were received; is an investigator for Chad Zuckerberg Initiative (CZI), Clayton Foundation for Research, National Eye Institute (NEI), and Research to Prevent Blindness (RPB), for which grant support was received.
Program Planning Committee
Hemakshi Adke - Nothing to Disclose
Aiyin Chen, M.D. - Nothing to Disclose
Julie Falardeau, M.D. - Nothing to Disclose
Seema Gupta, M.D. - Nothing to Disclose
Brooke Harkness, O.D. - Nothing to Disclose
Thomas Hwang, M.D. - Nothing to Disclose
Susan Minnieweather - Nothing to Disclose
Afshan Nanji, M.D. - Participated in a one -time paid trial of equipment for Beyeonics for which Consulting Fees were received.
Amanda Redfern, M.D. - Nothing to Disclose
Leah Reznick, M.D. - Nothing to Disclose
Daniel Tu, M.D., Ph.D. - Nothing to Disclose
Lorri Wilson, M.D. - Nothing to Disclose